ArticleArthritis and rheumatism2012

Addition of an indoleamine 2,3,-dioxygenase inhibitor to B cell-depletion therapy blocks autoreactive B cell activation and recurrence of arthritis in K/BxN mice.

Elizabeth Pigott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.